-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Downgrades Medpace Hldgs to Hold, Lowers Price Target to $328

Benzinga·04/14/2025 17:10:24
Listen to the news
TD Cowen analyst Charles Rhyee downgrades Medpace Hldgs (NASDAQ:MEDP) from Buy to Hold and lowers the price target from $370 to $328.